Ameritas Investment Partners’s OptimizeRx OPRX Stock Holding History
Bought
Maintained
Sold
Other funds holding OPRX
WCA
RA
PHP
VCM
KCM
RHJA
Ameritas Investment Partners's OPRX Position: Q1 2026 in Review
Ameritas Investment Partners held its OptimizeRx (OPRX) position steady in Q1 2026 at 1,258 shares worth $7.9K. The position accounts for ﹤0.01% of the portfolio, ranked #2908.
Ameritas Investment Partners first reported a position in OPRX in Q2 2019 and has held it in 28 quarters since. The position peaked at $108K in Q3 2021. 128 funds tracked by Wall St. Rank hold OPRX as of Q1 2026.
- Ameritas Investment Partners held 1,258 shares of OptimizeRx worth $7.9K as of Q1 2026.
- Ameritas Investment Partners left its OptimizeRx share count unchanged in Q1 2026.
- OptimizeRx made up ﹤0.01% of Ameritas Investment Partners's portfolio in Q1 2026, its #2908 holding.
- Ameritas Investment Partners first reported a position in OptimizeRx in Q2 2019 and has held it in 28 quarters since.
- Ameritas Investment Partners's OptimizeRx position peaked at $108K in Q3 2021.
- 128 funds tracked by Wall St. Rank held OptimizeRx as of Q1 2026.
Based on Ameritas Investment Partners's 13F filing for Q1 2026, filed 13 May 2026.